The new RSV vaccines for older adults - Mayo Clinic Press
Sep 19, 2023 · In May 2023, pharmaceutical companies GSK and Pfizer received approval from the U.S. Food and Drug Administration (FDA) for their RSV vaccines within weeks of each other. Both vaccines are currently available. Here’s what you need to know about RSV and the two new vaccines designed to protect against it. What is RSV?
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the prevention of...
CDC Revises RSV Vaccine Guidelines Over Side Effect Concerns - WebMD
Aug 7, 2024 · RSV vaccination is now recommended for all people ages 75 and older. People ages 60 to 74 who are at increased risk for severe disease due to RSV should also get vaccinated. Those...
CDC Updates RSV Vaccination Recommendation for Adults
Jun 26, 2024 · Today, CDC updated its recommendation for the use of Respiratory Syncytial Virus (RSV) vaccines in people ages 60 and older. For this upcoming respiratory virus season, CDC recommends: Everyone ages 75 and older receive the RSV vaccine.
U.S. FDA Approves Pfizer’s RSV Vaccine ABRYSVO® for Adults …
Oct 22, 2024 · ABRYSVO now offers the broadest RSV vaccine indication for adults, which previously included those 60 years and older. Additionally, it remains the only RSV immunization approved for pregnant individuals at 32 through 36 weeks of gestation to protect infants from birth up to 6 months of age.
FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
May 3, 2023 · After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV – and more are on the way. On Wednesday, the US Food and Drug Administration...
FDA approves Pfizer's RSV vaccine for adults at increased risk of …
Oct 22, 2024 · The U.S. Food and Drug Administration on Tuesday approved Pfizer 's RSV vaccine for the prevention of lower respiratory tract disease caused by RSV in adults aged 18 to 59 at increased risk of...
FDA approves Moderna’s mRNA RSV vaccine for older adults
May 31, 2024 · The US Food and Drug Administration has approved another vaccine to help protect older people from respiratory syncytial virus, known as RSV. The shot, made by Moderna and sold under the name...
Federal Officials Revise Recommendations for R.S.V. Vaccine
Jun 26, 2024 · Based on recent safety and effectiveness data, they unanimously recommended that all Americans age 75 and older receive one dose of an R.S.V. vaccine.
FDA Approves First Vaccine for Pregnant Individuals to Prevent RSV …
FDA approves Abrysvo for immunization at 32 through 36 weeks gestational age of pregnancy to prevent lower respiratory tract disease (LRTD) and severe LRTD caused by respiratory syncytial virus...